Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
Nabil NoureddinDaniel Q HuangRicki BettencourtHarris SiddiqiAbdul M MajzoubTarek NayfehNobuharu TamakiNamiki IzumiHirokazu TakahashiRamazan IdilmanMesut GumussoyDigdem Kuru OzAyse ErdenTolga GidenerAlina M AllenVeeral AjmeraStephen CaldwellPublished in: Alimentary pharmacology & therapeutics (2024)
The most common first liver-related event in MASLD patients is ascites. The median survival from the first hepatic decompensation to either death or transplantation is 2 years.